Crossmark

Treatment of type 2 diabetes by targeting interleukin-1: a meta-analysis of 2921 patients

Crossref DOI link: https://doi.org/10.1007/s00281-019-00743-6

Published Online: 2019-04-25

Published Print: 2019-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kataria, Yachana

Ellervik, Christina

Mandrup-Poulsen, Thomas https://orcid.org/0000-0002-3215-9273
Funding

Funding for this research was provided by:

N/A (N/A)
License Information

Text and Data Mining valid from 2019-04-25
More Information

Article History

Received: 5 March 2019

Accepted: 22 March 2019

First Online: 25 April 2019

Compliance with ethical standards

:

: The authors declare that they have no conflicts of interest.